Loading…
Vericel Corporation is projected to rise to $68.24 by 2027, a +45% move from its current price of $47.00. VCEL is currently trading above its 50-day average (a bullish sign). Technical indicators currently lean strong buy.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via Yahoo Finance · updated 7/12/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Jul 13 | $46.01 | $47.04 | $48.10 | +0.09% |
| Jul 14 | $45.63 | $47.08 | $48.59 | +0.18% |
| Jul 15 | $45.35 | $47.13 | $48.98 | +0.27% |
| Jul 16 | $45.12 | $47.17 | $49.31 | +0.36% |
| Jul 17 | $44.92 | $47.21 | $49.62 | +0.45% |
| Jul 18 | $44.75 | $47.25 | $49.90 | +0.54% |
| Jul 19 | $44.59 | $47.30 | $50.16 | +0.63% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $44.59 | $47.30 | $50.16 | +0.63% |
| Week 2 | $43.79 | $47.59 | $51.72 | +1.26% |
| Week 3 | $43.25 | $47.89 | $53.03 | +1.90% |
| Week 4 | $42.84 | $48.19 | $54.21 | +2.53% |
| Week 5 | $42.52 | $48.49 | $55.31 | +3.18% |
| Week 6 | $42.25 | $48.80 | $56.36 | +3.83% |
| Week 7 | $42.03 | $49.10 | $57.38 | +4.48% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
Vericel Corporation is a commercial-stage biopharmaceutical company that engages in the research, development, manufacture, and distribution of cellular therapies and specialty biologic products for sports medicine and severe burn care markets in North America. The company markets autologous cell therapy products MACI, an autologous cultured chondrocytes on porcine collagen membrane for the repair of symptomatic, and single or multiple full-thickness cartilage defects of the knee; Epicel, a permanent skin replacement humanitarian use device for the treatment of adult and pediatric patients with deep-dermal or full-thickness burns; and NexoBrid, a biological orphan product for eschar removal in adults and pediatric patients with deep partial-thickness and/or full-thickness thermal burns. Vericel Corporation was formerly known as Aastrom Biosciences, Inc.
and changed its name to Vericel Corporation in November 2014. The company was incorporated in 1989 and is headquartered in Burlington, Massachusetts.
Vericel Corporation, trading as VCEL, operates in the healthcare sector with a market capitalization of $2.36B and a current price of $46.23. It ranks 1913 by market capitalization among public companies. The stock’s near-term outlook is informed by a set of technical indicators and a defined 30-day trading range, while the longer-run forecast outlines a path of appreciation through 2030 and beyond.
A major floor 42.1% below — a decisive break under it would weaken the trend.
The nearest floor, 30.2% below — buyers have tended to step in here.
Price is pressing into resistance (2.8% away) — a breakout level to watch.
A major ceiling 23.8% above — clearing it would confirm fresh momentum.
Key VCEL support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of VCEL market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $47.17 | Sell | $47.02 | Sell |
| MA 10 | $46.38 | Buy | $45.90 | Buy |
| MA 20 | $43.06 | Buy | $43.57 | Buy |
| MA 50 | $38.08 | Buy | $39.77 | Buy |
| MA 100 | $36.16 | Buy | $37.81 | Buy |
| MA 200 | $36.32 | Buy | $37.57 | Buy |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 70.06 | Sell |
| Stoch RSI (14) | 0.79 | Buy |
| CCI (20) | 79.22 | Neutral |
| Williams %R (14) | -16.54 | Info |
| MACD (12,26,9) | 0.26 | Buy |
| ROC (12) | 16.37 | Buy |
| Bollinger %B (20,2) | 0.77 | Neutral |
| Stochastic %K (14) | 83.46 | Sell |
| TRIX (15) | 1.02 | Buy |
| Awesome (5,34) | 7.40 | Buy |
| Ultimate (7,14,28) | 72.95 | Sell |
| Momentum (10) | 4.10 | Buy |
| Aroon Osc (25) | 96.00 | Buy |
| Hull MA (9) | 47.93 | Sell |
| ADX (14) | 38.66 | Buy |
| ATR (14) | 0.90 | Info |
The near-term technical picture is bullish overall with momentum elevated. RSI14 stands at 80, indicating strong price momentum, while the price is above both the SMA50 ($35.83) and the SMA200 ($35.59), suggesting an upward bias. Support sits at $32.82 and resistance sits at $42.90, framing a near-term trading path.
The 30-day range spans from a low of $40.43 to a high of $52.87, showing ample upside potential within the month.
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $29.34 | $47.00 | $67.90 | 0% | Neutral | |
| $55.26 | $68.24 | $88.55 | +45% | Bullish | |
| $60.89 | $76.88 | $102.88 | +64% | Bullish | |
| $70.77 | $91.01 | $124.80 | +94% | Bullish | |
| $74.98 | $97.99 | $137.16 | +109% | Bullish | |
| $79.60 | $105.57 | $150.46 | +125% | Bullish | |
| $97.16 | $130.63 | $189.20 | +178% | Bullish | |
| $112.76 | $153.53 | $225.67 | +227% | Bullish | |
| $127.59 | $175.83 | $261.97 | +274% | Bullish | |
| $137.45 | $191.59 | $289.09 | +308% | Bullish | |
| $214.79 | $315.24 | $501.62 | +571% | Bullish | |
| $370.61 | $593.28 | $1,020.86 | +11.6x | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| July 2026 | $29.34 | $47.00 | $56.94 | +0.00% |
| August 2026 | $42.79 | $50.25 | $60.42 | +6.92% |
| September 2026 | $43.17 | $50.99 | $61.87 | +1.47% |
| October 2026 | $43.33 | $51.43 | $62.88 | +0.85% |
| November 2026 | $44.81 | $53.41 | $65.72 | +3.85% |
| December 2026 | $45.85 | $54.85 | $67.90 | +2.71% |
Click any year to see its month-by-month VCEL forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
Expect VCEL to range from $29.34 to $67.90 through 2026. The $47.00 average target implies a 0% move from current prices. A consolidation phase looks the most probable path here.
The VCEL price prediction for 2027 points to an average of $68.24 (low $55.26, high $88.55) — a potential gain of +45% on today's $47.00. Momentum favours further upside here.
In 2028, VCEL is projected to trade between $60.89 and $102.88, averaging $76.88 — a potential gain of +64% from today's $47.00. That is up +13% on the projected 2027 average. Buyers look set to stay in control over this stretch.
Vericel Corporation's 2029 outlook centres on $91.01, within a $70.77 to $124.80 range. That is up +18% on the projected 2028 average. That marks a +94% change versus current levels. Momentum favours further upside here.
By 2030, VCEL could reach as high as $137.16, with a base case around $97.99 and support toward $74.98 — roughly +109% from $47.00. Buyers look set to stay in control over this stretch.
Expect VCEL to range from $79.60 to $150.46 through 2031. The $105.57 average target implies a +125% move from current prices. That is up +8% on the projected 2030 average. Momentum favours further upside here.
The VCEL price prediction for 2032 points to an average of $130.63 (low $97.16, high $189.20) — a potential gain of +178% on today's $47.00. Buyers look set to stay in control over this stretch.
In 2033, VCEL is projected to trade between $112.76 and $225.67, averaging $153.53 — a potential gain of +227% from today's $47.00. That is up +18% on the projected 2032 average. Momentum favours further upside here.
Vericel Corporation's 2034 outlook centres on $175.83, within a $127.59 to $261.97 range. That is up +15% on the projected 2033 average. That marks a +274% change versus current levels. Buyers look set to stay in control over this stretch.
By 2035, VCEL could reach as high as $289.09, with a base case around $191.59 and support toward $137.45 — roughly +308% from $47.00. Momentum favours further upside here.
Expect VCEL to range from $214.79 to $501.62 through 2040. The $315.24 average target implies a +571% move from current prices. That is up +65% on the projected 2035 average. Buyers look set to stay in control over this stretch.
The VCEL price prediction for 2050 points to an average of $593.28 (low $370.61, high $1,020.86) — a potential gain of +11.6x on today's $47.00. Momentum favours further upside here.
Investing $1,000 in VCEL today (≈ 21.276596 VCEL) could be worth
$12,622.91
+$11,622.91 (+1162%) by 2050 · US Dollar
Based on the average projected VCEL price of $593.28 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in VCELwould be worth at today's price.
$1,000 invested in VCEL on Jul 10, 2025 (≈ 24.254184 VCEL) would be worth
$1,139.95
+$139.95 (+14.0%) today · 1.14× · US Dollar
Based on a VCEL entry price of $41.23 vs. today's $47.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $46.98 | $1,000.43 | +0.0% |
| 1 month ago | $37.38 | $1,257.36 | +25.7% |
| 3 months ago | $33.7 | $1,394.66 | +39.5% |
| 6 months ago | $36.59 | $1,284.5 | +28.5% |
| 1 year ago | $41.23 | $1,139.95 | +14.0% |
| All time (5.0y) ago | $53.57 | $877.36 | -12.3% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our VCEL forecast.
Our base-case forecast reaches $94.00 around 2030.
Implied market cap at $94.00: $4.8B
The multi-year forecast shows an upward trajectory in average prices and sizable positive ROI, starting in 2027 with a bullish tilt continuing through 2050. From 2026 to 2030 the average price rises from $46.23 to $89.06, with 2027 at $65.17 (ROI 41) and 2030 at $89.06 (ROI 92.7%). By 2033, the average is projected to $134.13 with a projected ROI of 190.1%, and by 2040 the average is $262.01 (ROI 466.8%).
The 2050 forecast shows an average of $463.17 with a ROI of 901.9%. The longer-term outlook is bullish, with higher confidence shown in the later years, but these are estimates and not guarantees.
Tap a question to reveal the answer.
The forecast shows an average price of $89.06 in 2030 with a projected ROI of 92.7%; the 2030 range includes a max of $122.93 and a min of $68.90.
Forecasts show neutral sentiment in 2026 (avg $46.23, ROI 0) followed by bullish sentiment from 2027 onward, with rising averages and positive ROIs (e.g., 2030 ROI 92.7%, 2035 ROI 250.1%, 2050 ROI 901.9%). These are estimates, not guarantees.
Yes. The year-by-year forecast shows increases that pass $100 in several years, with 2032-2033 having higher averages ($113.94 in 2032; $134.13 in 2033) and 2033's max at $193.72.
Current price is $46.23 and market cap is $2.36B.
The near-term technical picture is bullish with RSI14 at 80, price above SMA50 ($35.83) and SMA200 ($35.59); support at $32.82 and resistance at $42.90; 30-day range from $40.43 to $52.87.
Vericel Corporation Community Discussion
0Share your Vericel Corporation price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.